Literature DB >> 32576548

Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2020        PMID： 32576548     DOI： 10.1136/bmj.m2512

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

Review 1.  Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.

Authors:  Paul Eze; Kenechukwu N Mezue; Chidozie U Nduka; Ijeoma Obianyo; Obiora Egbuche
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

2.  Is Poliomyelitis Sequelae A Disadvantage for Recovery from Covid-19 ARDS: A Case Report.

Authors:  Mahir Topaloğlu; Zeynep Turan; Suda Tekin; Evren Şentürk; Özden Özyemişçi Taşkiran
Journal:  Noro Psikiyatr Ars       Date:  2022-04-12       Impact factor: 1.066

3.  Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19.

Authors:  Pradeep Singh Cheema; Deeptashree Nandi; Alo Nag
Journal:  Open Biol       Date:  2021-06-09       Impact factor: 6.411

4.  Identification and Development of Therapeutics for COVID-19.

Authors:  Halie M Rando; Nils Wellhausen; Soumita Ghosh; Alexandra J Lee; Anna Ada Dattoli; Fengling Hu; James Brian Byrd; Diane N Rafizadeh; Ronan Lordan; Yanjun Qi; Yuchen Sun; Christian Brueffer; Jeffrey M Field; Marouen Ben Guebila; Nafisa M Jadavji; Ashwin N Skelly; Bharath Ramsundar; Jinhui Wang; Rishi Raj Goel; YoSon Park; Simina M Boca; Anthony Gitter; Casey S Greene
Journal:  mSystems       Date:  2021-11-02       Impact factor: 6.496

Review 5.  The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19.

Authors:  Lauren A Callender; Michelle Curran; Stephanie M Bates; Maelle Mairesse; Julia Weigandt; Catherine J Betts
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

6.  Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight.

Authors:  Lucas A D Nicolau; Isabela R S G Nolêto; Jand V R Medeiros
Journal:  Expert Rev Clin Pharmacol       Date:  2020-07-25       Impact factor: 5.045

Review 7.  Opportunities for biomaterials to address the challenges of COVID-19.

Authors:  Daniel Chakhalian; Robert B Shultz; Catherine E Miles; Joachim Kohn
Journal:  J Biomed Mater Res A       Date:  2020-08-04       Impact factor: 4.854

8.  Safe administration of corticosteroids in severe ulcerative colitis and active SARS-CoV2 infection.

Authors:  Pierre Mayer; Antonio Saviano; Loïc Kassegne; Thomas F Baumert; Jean-Marie Reimund; François Habersetzer
Journal:  Dig Liver Dis       Date:  2020-07-27       Impact factor: 4.088

9.  Effect of IBD medications on COVID-19 outcomes: results from an international registry.

Authors:  Jean-Frederic Colombel; Michael D Kappelman; Ryan C Ungaro; Erica J Brenner; Richard B Gearry; Gilaad G Kaplan; Michele Kissous-Hunt; James D Lewis; Siew C Ng; Jean-Francois Rahier; Walter Reinisch; Flávio Steinwurz; Fox E Underwood; Xian Zhang
Journal:  Gut       Date:  2020-10-20       Impact factor: 31.793

10.  Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence.

Authors:  Khan Sharun; Ruchi Tiwari; Jaideep Dhama; Kuldeep Dhama
Journal:  Int J Surg       Date:  2020-09-04       Impact factor: 13.400
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.